Cortizone-10 Products
Allegations: Misleadingly marketing products as “Maximum Strength”
Tlaib et al. v. Chattem, Inc.
23-cv-376, N.D. Ill.
(Jan. 2023)
ACT Dry Mouth Lozenges
Failing to disclose that the product is detrimental to oral health due to having a pH level that is below the pH level of tooth enamel and root dentin, which contributes to demineralization, dental erosion, and sensitivity
Pending
Allegations: Misleadingly marketing products as “Maximum Strength”
Allegations: False natural claims
Allegations: False natural claims
In July 2013, a federal judge granted final approval of a settlement agreement reached in a false advertising class-action lawsuit against Chattem, Inc. The complaint, which was originally filed in…
May 2015: A federal judge granted Chattem Inc.’s motion to dismiss finding that the claim was preempted by federal law. February 2015: A false advertising class-action lawsuit was filed against…
February 2015: This action was dismissed for lack of subject matter jurisdiction. The dismissal was When a complaint is dismissed without prejudice, an amended version of the complaint can be…
TINA.org investigates after doctor challenges pain reliever’s “clinically proven” labeling claim on Twitter.
NAD tells marketer to watch its mouth when it comes to making certain dry mouth product claims.
Makers of nasal allergy spray told to cease consumer preference claims.